IWR-1
IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM) . IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis[1][2][4].
Product Specifications
CAS Number
1127442-82-3
Product Name Alternative
Endo-IWR 1; IWR-1-endo
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Organoid; Wnt
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/IWR-1.html
Purity
99.60
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NC1=C2N=CC=CC2=CC=C1)C3=CC=C(N(C([C@]4([H])[C@](C5)([H])C=C[C@]5([H])[C@]64[H])=O)C6=O)C=C3
Molecular Formula
C25H19N3O3
Molecular Weight
409.44
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Horse sCD14 (soluble cluster of differentiation 14) ELISA Kit
Horse sCD14 (soluble cluster of differentiation 14) ELISA Kit
Horse sCD14 (soluble cluster of differentiation 14) ELISA Kit